or
forgot password
  • cancer clinical trials in portland, OR

  • Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
    Legacy Good Samaritan Hospital and Medical Center

    Trial Locations
    Legacy Good Samaritan Hospital and Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
    Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
    Oregon Health and Science University
    Portland, Oregon 97201
    Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast, Malignant Melanoma
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Oregon Health and Science University
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care
    Kaiser Permanente Northwest
    Portland, Oregon 97227
    Primary Breast Cancer
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #27
    Portland, Oregon 97213-2996
    Metastatic Breast Cancer
    A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)
    Oregon Health and Science University-Knight Cancer Institute
    Portland, Oregon 97239
    Gastrointestinal Stromal Tumor
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    Oregon Health & Science Institute (OHSU)
    Portland, Oregon 97239
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Kaiser Permanente Oncology/Hematology
    Portland, Oregon 97227
    Prostate Cancer
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Legacy Good Samaritan Hospital and Medical Center
    Providence Saint Vincent Medical Center
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Oregon Health Sciences University
    Portland, Oregon
    Breast Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Northwest Cancer Specialists, PC
    Portland, Oregon 97225
    Metastatic Breast Cancer
    Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes

    Trial Locations
    US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes
    US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway
    US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt
    Chronic Lymphocytic Leukemia
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Malignant Mesothelioma
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Oregon Health and Science University

    Trial Locations
    Oregon Health and Science University
    Kaiser Permanente
    Legacy Good Samaritan Hospital and Medical Center
    Columbia River Oncology Program
    Breast Cancer
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    Oregon Health & Science University (A) and (P)
    Portland, Oregon 97239-3098
    Chronic GVHD
    Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
    Oregon Health and Sciences University

    Trial Locations
    Oregon Health and Sciences University
    Providence Cancer Center
    Solid Tumors, Glioblastoma Multiforme, Recurrent Malignant Gliomas
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Columbia River Oncology Program
    Portland, Oregon 97225
    Multiple Myeloma
    Triple Negative Breast Cancer Biomarker Study
    Northwest Cancer Specialists, P.C.
    Portland, Oregon 97227
    Metastatic Breast Cancer, Triple Negative Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Knight Cancer Institute at Oregon Health and Science University

    Trial Locations
    Knight Cancer Institute at Oregon Health and Science University
    Kaiser Permanente Health Care - Portland
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Kidney Cancer
    Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
    Oregon Health & Science University

    Trial Locations
    Oregon Health & Science University
    Oregon Health and Sciences University
    Acromegaly